NCT03770767View on ClinicalTrials.gov

Insulin Fiasp vs. Insulin Novorapid During Pregnancy and Laction in Women With Pre-existing Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

November 11, 2019

Primary Completion Date

March 23, 2023

Study Completion Date

March 23, 2023

Conditions
Diabetes MellitusPregnancy Complications
Interventions
DRUG

Faster-acting Aspart insulin Fiasp

Randomization to treatment with insulin Fiasp

DRUG

Control (insulin Novorapid)

Randomization to standard treatment with insulin Novorapid

Trial Locations (1)

Unknown

Center for Pregnant Women with Diabetes, Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT03770767 - Insulin Fiasp vs. Insulin Novorapid During Pregnancy and Laction in Women With Pre-existing Diabetes | Biotech Hunter | Biotech Hunter